223 related articles for article (PubMed ID: 24722244)
1. Metabolic crosstalk: molecular links between glycogen and lipid metabolism in obesity.
Lu B; Bridges D; Yang Y; Fisher K; Cheng A; Chang L; Meng ZX; Lin JD; Downes M; Yu RT; Liddle C; Evans RM; Saltiel AR
Diabetes; 2014 Sep; 63(9):2935-48. PubMed ID: 24722244
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response.
Li H; Min Q; Ouyang C; Lee J; He C; Zou MH; Xie Z
Biochim Biophys Acta; 2014 Sep; 1842(9):1844-54. PubMed ID: 25016145
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.
Pajvani UB; Qiang L; Kangsamaksin T; Kitajewski J; Ginsberg HN; Accili D
Nat Med; 2013 Aug; 19(8):1054-60. PubMed ID: 23832089
[TBL] [Abstract][Full Text] [Related]
4. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS
PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773
[TBL] [Abstract][Full Text] [Related]
5. Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation.
Kenerson HL; Yeh MM; Yeung RS
PLoS One; 2011 Mar; 6(3):e18075. PubMed ID: 21479224
[TBL] [Abstract][Full Text] [Related]
6. Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice.
Jiang H; Westerterp M; Wang C; Zhu Y; Ai D
Diabetologia; 2014 Nov; 57(11):2393-404. PubMed ID: 25120095
[TBL] [Abstract][Full Text] [Related]
7. Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism.
Guridi M; Kupr B; Romanino K; Lin S; Falcetta D; Tintignac L; Rüegg MA
Skelet Muscle; 2016; 6():13. PubMed ID: 27004103
[TBL] [Abstract][Full Text] [Related]
8. Liver glycogen reduces food intake and attenuates obesity in a high-fat diet-fed mouse model.
López-Soldado I; Zafra D; Duran J; Adrover A; Calbó J; Guinovart JJ
Diabetes; 2015 Mar; 64(3):796-807. PubMed ID: 25277398
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide prevents high-fat diet-induced obesity in C57BL/6 mice by suppressing the sterol regulatory element-binding protein pathway.
Ding L; Li J; Song B; Xiao X; Huang W; Zhang B; Tang X; Qi M; Yang Q; Yang Q; Yang L; Wang Z
J Pharmacol Exp Ther; 2014 Nov; 351(2):474-83. PubMed ID: 25204338
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between beta-adrenergic and insulin signaling mediates mechanistic target of rapamycin hyperactivation in liver of high-fat diet-fed male mice.
Ashraf S; Ashraf N; Yilmaz G; Harmancey R
Physiol Rep; 2021 Jul; 9(13):e14958. PubMed ID: 34231324
[TBL] [Abstract][Full Text] [Related]
12. Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice.
López-Soldado I; Guinovart JJ; Duran J
J Biol Chem; 2021; 296():100498. PubMed ID: 33667544
[TBL] [Abstract][Full Text] [Related]
13. 2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.
Zhang J; Zhang LN; Chen DM; Fu YY; Zhang F; Yang LL; Xia CM; Jiang HW; Tang CL; Xie ZF; Yang F; Li J; Tang J; Li JY
Acta Pharmacol Sin; 2015 Apr; 36(4):483-96. PubMed ID: 25832429
[TBL] [Abstract][Full Text] [Related]
14. Active Glycogen Synthase in the Liver Prevents High-Fat Diet-Induced Glucose Intolerance, Decreases Food Intake, and Lowers Body Weight.
López-Soldado I; Guinovart JJ; Duran J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768897
[TBL] [Abstract][Full Text] [Related]
15. Effects of hepatic glycogen on food intake and glucose homeostasis are mediated by the vagus nerve in mice.
López-Soldado I; Fuentes-Romero R; Duran J; Guinovart JJ
Diabetologia; 2017 Jun; 60(6):1076-1083. PubMed ID: 28299379
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.
Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA
Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.
Xu JL; Li LY; Wang YQ; Li YQ; Shan M; Sun SZ; Yu Y; Wang B
J Lipid Res; 2018 Jan; 59(1):35-47. PubMed ID: 29113994
[TBL] [Abstract][Full Text] [Related]
18. Fisetin regulates obesity by targeting mTORC1 signaling.
Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
[TBL] [Abstract][Full Text] [Related]
19. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
20. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.
Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R
Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
